Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells

AbstractGlucocorticoids (GC) induce cell cycle arrest and apoptosis in lymphoblastic leukemia cells. To investigate cell cycle effects of GC in the absence of obscuring apoptotic events, we used human CCRF-CEM leukemia cells protected from cell death by transgenic bcl-2. GC treatment arrested these cells in the G1 phase of the cell cycle due to repression of cyclin D3 and c-myc. Cyclin E and Cdk2 protein levels remained high, but the kinase complex was inactive due to increased levels of bound p27Kip1. Conditional expression of cyclin D3 and/or c-myc was sufficient to prevent GC-induced G1 arrest and p27Kip1 accumulation but, importantly, did not interfere with the induction of apoptosis. The combined data suggest that repression of both, c-myc and cyclin D3, is necessary to arrest human leukemia cells in the G1 phase of the cell division cycle, but that neither one is required for GC-induced apoptosis.

[1]  M. Hirai,et al.  c-Myc and cyclin D3 (CcnD3) genes are independent targets for glucocorticoid inhibition of lymphoid cell proliferation. , 1995, Cancer research.

[2]  R. Evans,et al.  Molecular characterization of the glucocorticoid receptor. , 1989, Recent progress in hormone research.

[3]  S. Okret,et al.  p57Kip2, a glucocorticoid-induced inhibitor of cell cycle progression in HeLa cells. , 1999, Molecular endocrinology.

[4]  R. Kofler,et al.  Genes mediating glucocorticoid effects and mechanisms of their regulation. , 1996, Reviews of physiology, biochemistry and pharmacology.

[5]  Miguel Beato,et al.  Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.

[6]  Stella Pelengaris,et al.  c-MYC: more than just a matter of life and death , 2002, Nature Reviews Cancer.

[7]  M. Pagano,et al.  Differential modulation of cyclin gene expression by MYC. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G P Nolan,et al.  High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. , 1998, Cancer research.

[9]  D. Reisman,et al.  Glucocorticoid regulation of cyclin D3 gene transcription and mRNA stability in lymphoid cells. , 1995, Molecular endocrinology.

[10]  R. Greil,et al.  The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells. , 1997, FEBS letters.

[11]  I. Screpanti,et al.  Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoid hormones in human T lymphoblastic leukemic cells. , 1990, Nucleic Acids Research.

[12]  A. Hatzigeorgiou,et al.  Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter , 1996, Molecular and cellular biology.

[13]  M. Eilers,et al.  Control of cell proliferation by Myc. , 1998, Trends in cell biology.

[14]  E. Cundari,et al.  Dexamethasone induces apoptosis in human T cell clones expressing low levels of Bcl-2 , 1999, Cell Death and Differentiation.

[15]  R. Greil,et al.  The interleukin 1β‐converting enzyme inhibitor CrmA prevents Apo1/Fas‐ but not glucocorticoid‐induced poly(ADP‐ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells , 1997 .

[16]  D. Bernhard,et al.  Gene expression profiles of proliferating vs. G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid‐induced apoptosis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  E. A. Thompson,et al.  Glucocorticoid inhibition of fibroblast proliferation and regulation of the cyclin kinase inhibitor p21Cip1. , 1997, Molecular endocrinology.

[18]  U. Certa,et al.  Expression profiling of glucocorticoid-treated T-ALL cell lines: rapid repression of multiple genes involved in RNA-, protein- and nucleotide synthesis , 2001, Oncogene.

[19]  D. Bernhard,et al.  c-Myc does not prevent glucocorticoid-induced apoptosis of human leukemic lymphoblasts , 1999, Oncogene.

[20]  F. Alt,et al.  Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression. , 2000, Genes & development.

[21]  R. Kofler,et al.  Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line. , 1995, Cancer research.

[22]  J. Bartek,et al.  Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 , 1995, Nature.

[23]  J. Bishop,et al.  The MYC protein activates transcription of the alpha‐prothymosin gene. , 1991, The EMBO journal.

[24]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  B. Amati,et al.  Cyclin E and c‐Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins , 1997, The EMBO journal.

[26]  R. Pieters,et al.  Glucocorticoid resistance in childhood leukemia. , 1994, Leukemia & lymphoma.

[27]  D. Littman,et al.  Nuclear Hormone Receptors in T Lymphocytes , 2002, Cell.

[28]  W. Ansorge,et al.  Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27 , 1999, The EMBO journal.

[29]  E. Thompson,et al.  Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis. , 1993, The Journal of biological chemistry.

[30]  John M. Sedivy,et al.  c-Myc Regulates Cyclin D-Cdk4 and -Cdk6 Activity but Affects Cell Cycle Progression at Multiple Independent Points , 1999, Molecular and Cellular Biology.

[31]  K. Tanaka,et al.  Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. , 1994, Blood.

[32]  R. Kofler,et al.  Bcl-2 interferes with the execution phase, but not upstream events, in glucocorticoid-induced leukemia apoptosis , 1999, Oncogene.

[33]  A. Sewing,et al.  Cyclins D1 and D2 mediate Myc‐induced proliferation via sequestration of p27Kip1 and p21Cip1 , 1999, The EMBO journal.

[34]  R. Kofler,et al.  The molecular basis of glucocorticoid-induced apoptosis of lymphoblastic leukemia cells , 2000, Histochemistry and Cell Biology.

[35]  J. Cidlowski,et al.  Cell cycle regulation and apoptosis. , 1998, Annual review of physiology.

[36]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[37]  E. Lees,et al.  Cyclin D-CDK Subunit Arrangement Is Dependent on the Availability of Competing INK4 and p21 Class Inhibitors , 1999, Molecular and Cellular Biology.

[38]  E. Thompson,et al.  Glucocorticoid mediated transcriptional repression of c-myc in apoptotic human leukemic CEM cells , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[39]  A. Murray,et al.  The Cell Cycle: An Introduction , 1993 .

[40]  L. M. Facchini,et al.  Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. , 1994, Oncogene.

[41]  N. Krett,et al.  Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[42]  E. Harlow,et al.  The retinoblastoma tumour suppressor in development and cancer , 2002, Nature Reviews Cancer.

[43]  R. Eisenman,et al.  Myc target genes. , 1997, Trends in biochemical sciences.

[44]  M. Garabedian,et al.  Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms , 1997, Molecular and cellular biology.

[45]  W. Tissing,et al.  Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia , 2003, Leukemia.

[46]  M. Garabedian,et al.  Distinct Glucocorticoid Receptor Transcriptional Regulatory Surfaces Mediate the Cytotoxic and Cytostatic Effects of Glucocorticoids , 1999, Molecular and Cellular Biology.

[47]  Andreas Sewing,et al.  Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27Kip1 binding to newly formed complexes , 1997, Oncogene.

[48]  E. Thompson,et al.  Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells , 2001, Oncogene.

[49]  J. Bartek,et al.  Aberrations of p16Ink4 and retinoblastoma tumour‐suppressor genes occur in distinct sub‐sets of human cancer cell lines , 1995, International journal of cancer.

[50]  R. Kofler,et al.  The Cell Cycle Inhibitor p16INK4A Sensitizes Lymphoblastic Leukemia Cells to Apoptosis by Physiologic Glucocorticoid Levels* , 2001, The Journal of Biological Chemistry.

[51]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[52]  C. Pui.  Childhood Leukemias: Acute lymphoblastic leukemia , 2006 .

[53]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[54]  D. Green.  Apoptotic Pathways The Roads to Ruin , 1998, Cell.

[55]  R. Kofler,et al.  Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression. , 1996, Cancer research.

[56]  C. Pui.  Medical progress : childhood leukemias , 1995 .

[57]  Apoptosis and steroid hormones. , 1994, Molecular endocrinology.

[58]  S. Reed,et al.  Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. , 2000, Current opinion in cell biology.

[59]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[60]  S. Planey,et al.  Glucocorticoid-induced apoptosis in lymphocytes. , 2000, Biochemical and biophysical research communications.